Resistance to Lamivudine in HBV Egyptian Patients

A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

NCT00489151 ·Status: UNKNOWN ·Phase: NA

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

NCT01013272 ·Status: COMPLETED ·Phase: NA

A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone

NCT00354653 ·Status: COMPLETED ·Phase: PHASE4

Long-Term Lamivudine Therapy for Chronic Hepatitis B

NCT00120354 ·Status: COMPLETED ·Phase: PHASE4

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients

NCT04480294 ·Status: UNKNOWN ·Phase: PHASE1

Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients

NCT00823550 ·Status: UNKNOWN ·Phase: PHASE4

Plasma Purification and Chronic Hepatitis B

NCT04518553 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients

NCT01487876 ·Status: UNKNOWN ·Phase: PHASE2

A Randomized Controlled Trial of Lamivudine in Acute Hepatitis B

NCT00380614 ·Status: COMPLETED ·Phase: PHASE4

A Phase II Dose Response Study in Japan in Chronic Hepatitis B

NCT01022801 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

NCT00798460 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection

NCT03186313 ·Status: COMPLETED ·Phase: PHASE3

Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial

NCT01152060 ·Status: UNKNOWN

Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)

NCT00120796 ·Status: TERMINATED ·Phase: PHASE3

Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B

NCT06896630 ·Status: NOT_YET_RECRUITING

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

NCT00023153 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Optimizing Research of Lamivudine Therapy

NCT01088009 ·Status: COMPLETED ·Phase: PHASE4

Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents

NCT02337127 ·Status: UNKNOWN ·Phase: PHASE4

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

NCT00140725 ·Status: COMPLETED ·Phase: PHASE3

Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation

NCT01848743 ·Status: UNKNOWN ·Phase: PHASE3

Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection

NCT01480492 ·Status: COMPLETED ·Phase: NA

Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis

NCT00076336 ·Status: COMPLETED ·Phase: PHASE3

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

NCT00230477 ·Status: COMPLETED ·Phase: PHASE4

Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B

NCT01743079 ·Status: COMPLETED ·Phase: PHASE4

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

NCT00013702 ·Status: COMPLETED ·Phase: PHASE2